Sign In
Buy REFR
$0.760
+0 (+0%)
At Close: Jun 03, 2026
- The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα expression of 25% or greater - - The late-breaking oral presentati
Research Frontiers Incorporated (REFR) Q4 2024 Earnings Call Transcript
08:43pm, Thursday, 06'th Mar 2025
Research Frontiers Incorporated (NASDAQ:REFR ) Q4 2024 Earnings Conference Call March 6, 2025 4:30 PM ET Company Participants Joe Harary - President & Chief Executive Officer Conference Call Participa
Research Frontiers Reports 2024 Financial Results and Will Host a Conference Call at 4:30p.m. Today
04:01pm, Thursday, 06'th Mar 2025
WOODBURY, N.Y., March 06, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR ) announced its financial results for its fourth quarter and full-year 2024. Management will host a conferenc
RESEARCH FRONTIERS TO HOST YEAR-END 2024 CONFERENCE CALL
09:00am, Monday, 03'rd Mar 2025
WOODBURY, NY, March 03, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its fourth quarter and full-year 2024 financial results on Thursday, Mar
Research Frontiers Incorporated (REFR) Q3 2024 Earnings Call Transcript
07:20pm, Friday, 08'th Nov 2024
Research Frontiers Incorporated (NASDAQ:REFR ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Joe Harary - President and CEO Operator Good afternoon, ladies and gent
RESEARCH FRONTIERS TO HOST THIRD QUARTER 2024 CONFERENCE CALL
08:30am, Monday, 04'th Nov 2024
WOODBURY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR ) announced today that it will release its third quarter 2024 financial results on Thursday, November 7, 2024.
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format
Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer
08:00am, Thursday, 22'nd Aug 2024
SOUTH SAN FRANCISCO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format
Research Frontiers, Inc. (REFR) Q2 2024 Earnings Call Transcript
02:26pm, Friday, 02'nd Aug 2024
Research Frontiers, Inc. (NASDAQ:REFR ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Joe Harary - President & CEO Conference Call Participants Neal Goldman - Goldman
Research Frontiers Reports Second Quarter 2024 Financial Results and Will Host a Conference Call at 4:30p.m. Today
04:01pm, Thursday, 01'st Aug 2024
WOODBURY, N.Y., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR ) announced its financial results for its second quarter of 2024. Management will host a conference call today a
RESEARCH FRONTIERS TO HOST SECOND QUARTER 2024 CONFERENCE CALL
08:30am, Monday, 29'th Jul 2024
WOODBURY, NY, July 29, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR ) announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024.
Washington DC, June 06, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR), the inventor and licensor of patented SPD-Smart film light-control technology, and AIT Group, a fully-integrate
Research Frontiers, Inc. (REFR) Q1 2024 Earnings Call Transcript
02:06pm, Wednesday, 15'th May 2024
Research Frontiers, Inc. (NASDAQ:REFR ) Q1 2024 Earnings Conference Call May 9, 2024 5:30 PM ET Company Participants Joe Harary - President & CEO Conference Call Participants Michael Kay - Kay Associa
RESEARCH FRONTIERS TO HOST FIRST QUARTER 2024 CONFERENCE CALL
08:30am, Monday, 06'th May 2024
WOODBURY, NY, May 06, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its first quarter 2024 financial results on Thursday, May 9, 2024. Researc
Research Frontiers Incorporated (REFR) Q4 2023 Earnings Call Transcript
09:55pm, Thursday, 07'th Mar 2024
Research Frontiers Incorporated (NASDAQ:REFR ) Q4 2023 Earnings Conference Call March 7, 2024 4:30 PM ET Company Participants Joe Harary – President and Chief Executive Officer Conference Call Parti
